Results 11 to 20 of about 25,438 (199)

MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma

open access: yesOncoImmunology, 2022
The major histocompatibility complex-class I chain related proteins A and B (MICA/B) is upregulated because of cellular stress and MICA/B shedding by cancer cells causes escape from NKG2D recognition favoring the emergence of cancers. Cholangiocarcinoma (
Barbara Oliviero   +18 more
doaj   +1 more source

ADCC: An underappreciated correlate of cross-protection against influenza?

open access: yesFrontiers in Immunology, 2023
In this short review, we summarized the results obtained with an assay to detect influenza virus-specific antibodies that mediate ADCC, which was developed and evaluated within the framework of the IMI-funded project “FLUCOP”. HA-specific ADCC mediating antibodies were detected in serum samples from children and adults pre- and post-vaccination with ...
de Vries, Rory D.   +2 more
openaire   +3 more sources

Development of a Macrophage-Based ADCC Assay [PDF]

open access: yesVaccines, 2021
Fc-dependent effector functions are an important determinant of the in vivo potency of therapeutic antibodies. Effector function is determined by the combination of FcRs bound by the antibody and the cell expressing the relevant FcRs, leading to antibody-dependent cellular cytotoxicity (ADCC).
Melissa B. Uccellini   +4 more
openaire   +3 more sources

Do Instabilities in National Macroeconomic Factors Contribute to Channeling Volatility Spillover from the Global to the Islamic Equity Market?

open access: yesComparative Economic Research, 2021
This study investigates the impact of macroeconomic instabilities on returns volatility spillover that is transmitted from the global to the Islamic equity market.
Harjum Muharam   +3 more
doaj   +1 more source

Modulation of anti-tumour immunity by XPO1 inhibitors [PDF]

open access: yesExploration of Targeted Anti-tumor Therapy
Exportin-1 (XPO1) is a nuclear export protein that, when overexpressed, can facilitate cancer cell proliferation and survival and is frequently overexpressed or mutated in cancer patients.
Jack G. Fisher   +5 more
doaj   +1 more source

BAFF receptor antibody for mantle cell lymphoma therapy

open access: yesOncoImmunology, 2021
Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin’s lymphoma and remains incurable under current treatment modalities. One of the main reasons for treatment failure is the development of drug resistance.
Keman Zhang   +8 more
doaj   +1 more source

Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies

open access: yeseLife, 2021
A prerequisite for the design of an HIV vaccine that elicits protective antibodies is understanding the developmental pathways that result in desirable antibody features. The development of antibodies that mediate antibody-dependent cellular cytotoxicity
Laura E Doepker   +15 more
doaj   +1 more source

Combination Strategies to Enhance Antitumor ADCC [PDF]

open access: yesImmunotherapy, 2012
The clinical efficacy of monoclonal antibodies as cancer therapeutics is largely dependent upon their ability to target the tumor and induce a functional antitumor immune response. This two-step process of ADCC utilizes the response of innate immune cells to provide antitumor cytotoxicity triggered by the interaction of the Fc portion of the antibody ...
Holbrook E, Kohrt   +7 more
openaire   +2 more sources

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

open access: yesOncoImmunology, 2017
The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-
Riccardo Turrini   +10 more
doaj   +1 more source

Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines

open access: yesnpj Vaccines, 2022
Zoster vaccines generate antibody responses against varicella-zoster virus (VZV). We compared antibody-dependent cell cytotoxicity (ADCC) elicited by zoster vaccine live (ZVL) and recombinant zoster vaccine (RZV).
Seong Yeon Park   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy